Frontlight ResearchEarly access
Trial site
Soedra Aelvsborg Hospital Vaestra Goetalandsregionen
- 8running trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma5 trials
- Triple-negative breast cancer2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- High blood pressure1 trial
- Mantle cell lymphoma1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 34 trials
- Phase 1/22 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Recruiting5 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Merck Sharp & Dohme LLC2 trials
- AbbVie1 trial
- AbbVie Deutschland GmbH & Co. KG1 trial
- Boehringer Ingelheim1 trial
- Pfizer1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Discontinuation Outcome in Multiple Myeloma after BCMA-CD3 treatment
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma3 recruiting
- Triple-negative breast cancer2 recruiting
- High blood pressure1 recruiting
- Type 2 diabetes1 recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026